Clinical Lymphoma Myeloma & Leukemia
期刊信息导读
- Clinical Lymphoma Myeloma & Leukemia基本信息
- Clinical Lymphoma Myeloma & Leukemia中科院SCI期刊分区
- 历年Clinical Lymphoma Myeloma & Leukemia影响因子趋势图
- Clinical Lymphoma Myeloma & Leukemia期刊英文简介
- Clinical Lymphoma Myeloma & Leukemia期刊中文简介
Clinical Lymphoma Myeloma & Leukemia基本信息
简称：CL LYMPH MYELOM LEUK
中文名称：临床淋巴瘤骨髓瘤和白血病
研究方向：医学
2018-2019最新影响因子：2.274
2022年6月28日更新影响因子：2.822
SCI类别：SCIE
是否OA开放访问：No
出版地：UNITED STATES
出版周期：Bimonthly
创刊年份：2010
年文章数：148
涉及的研究方向：医学-血液学
通讯方式：CIG MEDIA GROUP, LP, 3500 MAPLE AVENUE, STE 750, DALLAS, USA, TX, 75219-3931
官方网站：http://www.journals.elsevier.com/clinical-lymphoma-myeloma-and-leukemia
投稿网址：http://ees.elsevier.com/clml/
审稿速度：较慢,6-12周
平均录用比例:较易
PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2152-2650%5BISSN%5D
Clinical Lymphoma Myeloma & Leukemia期刊英文简介
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
Clinical Lymphoma Myeloma & Leukemia期刊中文简介
《临床淋巴瘤、骨髓瘤和白血病》是一本同行评议的月刊，发表了描述淋巴瘤、骨髓瘤和白血病临床和转化研究各个方面的原始文章。《临床淋巴瘤、骨髓瘤和白血病》专门研究淋巴瘤、骨髓瘤、白血病和相关疾病的检测、诊断、预防和治疗，包括巨球蛋白血症、淀粉样变性和浆细胞贫血。重点是淋巴瘤、骨髓瘤和白血病相关领域的最新科学进展。感兴趣的特定领域包括临床研究和机械方法；药物敏感性和耐药性；基因和反义疗法；病理学、标记物和预后指标；化学预防策略；多模式疗法；以及各种方法的整合。
中科院SCI期刊分区：
Clinical Lymphoma Myeloma & Leukemia影响因子
获取相关优质资源获取2023中科院分区
![goback](data:image/svg+xml;charset=utf-8,<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 20"><path d="M10,0l2,2l-8,8l8,8l-2,2L0,10L10,0z" fill="%23fff"/></svg>){kind=icon}
